SAN
FRANCISCO, June 12, 2023 /PRNewswire/ -- Nektar
Therapeutics' (Nasdaq: NKTR) senior management is scheduled to
participate in a virtual fireside chat at the upcoming Goldman
Sachs 44th Annual Global Healthcare Conference on
Wednesday, June 14, 2023 at
1:20 p.m. Pacific Time.
The presentation will be accessible via a webcast through a link
posted on the Investor Events section of the Nektar website:
http://ir.nektar.com/events-and-presentations/events. This Webcast
will be available for replay until July 14,
2023.
About Nektar
Nektar Therapeutics is a
biopharmaceutical company with a robust, wholly owned R&D
pipeline of investigational medicines in immunology and oncology as
well as a portfolio of approved partnered medicines. Nektar is
headquartered in San Francisco,
California, with additional manufacturing operations in
Huntsville, Alabama. Further
information about the company and its drug development programs and
capabilities may be found online at http://www.nektar.com.
Contact:
For Investors:
Vivian
Wu of Nektar Therapeutics
628-895-0661
For Media:
David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nektar-therapeutics-to-participate-in-fireside-chat-at-the-goldman-sachs-44th-annual-global-healthcare-conference-301848750.html
SOURCE Nektar Therapeutics